作者:Matthew N. Mattson、Martin L. Neitzel、David A. Quincy、Christopher M. Semko、Albert W. Garofalo、Pamela S. Keim、Andrei W. Konradi、Michael A. Pleiss、Hing L. Sham、Elizabeth F. Brigham、Erich G. Goldbach、Hongbin Zhang、John-Michael Sauer、Guriqbal S. Basi
DOI:10.1016/j.bmcl.2010.02.050
日期:2010.4
Utilizing a pharmacophore hypothesis, previously described gamma-secretase inhibiting HTS hits were evolved into novel tricyclic sulfonamide-pyrazoles, with high in vitro potency, good brain penetration, low metabolic stability, and high clearance. (C) 2010 Elsevier Ltd. All rights reserved.